Cargando…

SUN-396 Denosumab Preserves Bone Mineral Density at the Knee in Persons with Subacute Spinal Cord Injury

Despite clinical strides in the treatment of osteoporosis in several diverse medical conditions, the ability to maintain bone has proven to be exceedingly difficult in individuals with severe immobilization. Fifty to 60% of bone mineral density (BMD) at the epiphyseal and metaphyseal regions of the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bauman, William Alan, Cirnigliaro, Christopher M, Fountaine, Michael F La, Hobson, Josh, Kirshblum, Steven C, McKenna, Christin, Spungen, Ann M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Bone and Mineral Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208425/ http://dx.doi.org/10.1210/jendso/bvaa046.144

Ejemplares similares

SUN-342 Effect of Hyperglycemia on Bone Mineral Density and Fracture in Pre-Liver Transplant Recipients
por: Abate, Ejigayehu G, et al.
Publicado: (2020)

Administration of Denosumab Preserves Bone Mineral Density at the Knee in Persons With Subacute Spinal Cord Injury: Findings From a Randomized Clinical Trial
por: Cirnigliaro, Christopher M, et al.
Publicado: (2020)

SUN-391 Denosumab Treatment of Patients with Osteoporosis and Idiopathic Hypercalciuria
por: Chu, Winston S, et al.
Publicado: (2020)

SUN-513 Parathyromatosis: A Case of Stubborn Hypercalcemia Treated with Denosumab
por: Ventura, Kenilia, et al.
Publicado: (2019)

SUN-514 Severe Hypophosphatemia and Worsening Secondary Hyperparathyroidism Following Treatment with Denosumab
por: Adepoju, Yewande, et al.
Publicado: (2019)

SUN-377 Efficacy of Low Dose Denosumab in Maintaining Bone Mineral Density in Postmenopausal Women with Osteoporosis: A Real World, Prospective Observational Study
por: Khan, Aliya Aziz, et al.
Publicado: (2020)

SUN-512 Denosumab Improves Trabecular but Not Cortical Bone Osteoporosis in a Patient with Refractory Primary Hyperparathyroidism
por: Alhassan, Sharifa, et al.
Publicado: (2019)

OR13-06 Romosozumab After Denosumab Improves Lumbar Spine Bone Mineral Density And Microarchitecture Greater Than Denosumab Continuation In Postmenopausal Women
por: Hong, Namki, et al.
Publicado: (2023)

MON-396 A Critical Review of the Assessment of Vitamin D Status
por: Chausmer, Arthur B
Publicado: (2020)

SUN-LB090 Accounting for Skeletal Maturation in the Assessment of Pediatric Bone Mineral Density
por: McCormack, Shana, et al.
Publicado: (2019)

SUN-371 Hyponatremia Correction Normalizes Bone Mineral Density and Bone Fragility in Rats
por: Xu, Qin, et al.
Publicado: (2020)

SUN-392 Bone Mineral Density and Body Mass Index in Men with Cystic Fibrosis
por: Jawahar, Abhinaya, et al.
Publicado: (2020)

SAT-396 A Non-Surgical Animal Model of Hypoparathyroidism for Testing PTH Analogues
por: Ramezani-Pour, Narjes, et al.
Publicado: (2020)

SAT-499 Denosumab for Treatment of Hypercalcemia in Myelofibrosis
por: Wong, Beatrice, et al.
Publicado: (2019)

MON-356 Atypical Femur Fracture with Denosumab
por: Mirza, Faryal S, et al.
Publicado: (2020)

ODP085 Denosumab Induced Severe Hypophosphatemia
por: Del Mar Morales Hernandez, Maria, et al.
Publicado: (2022)

SUN-352 The Effects of Acute Hyponatremia on Bone Remodeling Markers in Patients with Subarachnoid Hemorrhage
por: Garrahy, Aoife, et al.
Publicado: (2020)

SAT-509 Denosumab Use in Tertiary Hiperparathyroidism with Fracture
por: Coy, Andres, et al.
Publicado: (2019)

SUN-337 Low Dose Ethinyl Estradiol in Women with Cystic Fibrosis Does Not Preserve Bone Mass
por: Wu, Malinda, et al.
Publicado: (2020)

Denosumab Induced Severe Prolonged Hypocalcemia in Metastatic Prostate Cancer
por: Mehmood, Hassan, et al.
Publicado: (2021)

Rebound Hypercalcemia After Denosumab Therapy in a Child With Cherubism
por: Litao, Melissa Kaori S, et al.
Publicado: (2021)

SUN-543 Myostatin Inhibits IGF1-Dependent Citrate Production during Osteogenesis in a Mouse Mesenchymal Stem Cell Line
por: Liu, Xin-Hua, et al.
Publicado: (2019)

SUN-348 Growth Hormone Replacement in Adults During 8 Years Leads to Sustained Increase in Bone Mineral Density
por: Payer, Juraj, et al.
Publicado: (2020)

MON-517 Treatment of Gorham-Stout Disease with Combination Sirolimus and Denosumab
por: Hartley, Iris, et al.
Publicado: (2019)

Denosumab Induced Severe Hypocalcemia in a Patient With Metastatic Prostate Cancer
por: Naher, Kamrun, et al.
Publicado: (2021)

OR01-5 Transition From Low Dose Denosumab 30mg to IV Zoledronic Acid: Effect on Bone Mineral Density in Postmenopausal Women with Osteoporosis: A Prospective Observational Study
por: Ibrahim, Quazi, et al.
Publicado: (2022)

SUN-LB093 Change in Bone Mineral Density over One Year Was Not Associated with FGF-23 in Patients New to Dialysis
por: Roy, Neil, et al.
Publicado: (2019)

SUN-355 Associations of Trabecular Bone Score and Bone Mineral Density with Cardiorespiratory Fitness and Body Composition in Men with and Without Paraplegia
por: Usuga, Daniela, et al.
Publicado: (2020)

Impact of Thyroid Disease on Bone Mineral Density Preservation in Patients With Osteoporosis and Idiopathic Hypercalciuria
por: Chu, James W
Publicado: (2021)

SAT-532 Bisphosphonates Prevent Bone Loss Associated with Denosumab Treatment Discontinuation
por: Zanchetta, Maria Belen, et al.
Publicado: (2019)

MON-335 Bisphosphonate and Denosumab Refractory Hypercalcemia of Malignancy: What Else Is at Play?
por: Patel, Reshma, et al.
Publicado: (2020)

Prolonged Hypocalcemia After a Single Dose of Denosumab in Chronic Kidney Disease
por: Puar, Akshan, et al.
Publicado: (2021)

PSAT197 Treatment of Paget's Disease of the Skull With Denosumab: A Case Report
por: Torfah, Maisoon, et al.
Publicado: (2022)

FRI685 Denosumab Withdrawal Is Associated With Hypercalcemia In Adults With Osteoporosis And Bone Metastases
por: Patil, Madhuri D, et al.
Publicado: (2023)

THU448 Multiple Non-traumatic Vertebral Fractures After Discontinuation Of Denosumab
por: Riahi, Shayan, et al.
Publicado: (2023)

SUN-534 Effect of Cross-Sex Hormone Therapy on Body Composition, Visceral Adipose Tissue, and Bone Mineral Density in Transgender Men
por: Fighera, Tayane, et al.
Publicado: (2019)

THU396 Digital Spatial Profiling Of Human Parathyroid Tumors Reveals Distinct Cellular And Molecular Alterations Linked To Vitamin D Deficiency
por: Tu, Chia-Ling, et al.
Publicado: (2023)

Efficacy of Low Dose Denosumab in Maintaining Bone Mineral Density in Postmenopausal Women With Osteoporosis Switching From 60mg to 30mg 6 Monthly: A Real World, Prospective Observational Study
por: Khan, Aliya, et al.
Publicado: (2021)

Rebound-Associated Vertebral Fractures Two Months After a Missed Dose of Denosumab
por: Caseja, Ahl Jeffrey, et al.
Publicado: (2021)

SAT258 Successful Treatment Of Adult T-cell Leukemia-lymphoma Induced Hypercalcemia With Denosumab
por: Yuksel, Simge, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_oghfshin3pb6hjmvrtg76fbkms